VEGFA Amplification Reduced Survival in Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prognostic and Predictive Value of Tumor VEGF Gene Amplification in Metastatic Breast Cancer Treated With Paclitaxel With and Without Bevacizumab; Results From ECOG 2100 Trial
Clin. Cancer Res 2013 Jan 22;[EPub Ahead of Print], BP Schneider, R Gray, M Radovich, et alFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.